Otsuka (OTCMKTS:OTSKY) Stock Passes Above 50-Day Moving Average – What’s Next?

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY)’s share price passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $35.93 and traded as high as $38.1525. Otsuka shares last traded at $37.86, with a volume of 19,784 shares trading hands.

Otsuka Price Performance

The firm has a market cap of $40.67 billion, a price-to-earnings ratio of 15.20, a P/E/G ratio of 2.74 and a beta of -0.04. The stock’s fifty day moving average price is $35.93 and its 200-day moving average price is $34.78. The company has a current ratio of 2.17, a quick ratio of 1.67 and a debt-to-equity ratio of 0.05.

Otsuka (OTCMKTS:OTSKY) last issued its quarterly earnings data on Friday, July 31st. The company reported $0.70 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.19. The company had revenue of $4.41 billion during the quarter, compared to analyst estimates of $3.95 billion. Otsuka had a return on equity of 12.93% and a net margin of 15.50%.Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS. As a group, equities research analysts forecast that Otsuka Holdings Co., Ltd. – Unsponsored ADR will post 2.23 earnings per share for the current fiscal year.

About Otsuka

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.